LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.97 | 17.25 | 51 | 5618 | 0.0091 | 0.1387 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.97 | 17.25 | 6206 | 5618 | 1.1045 | 1.0240 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.97 | 17.25 | 5319 | 5618 | 0.9466 | 0.9869 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.97 | 17.25 | 6020 | 5618 | 1.0714 | 1.0166 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.97 | 17.25 | 17 | 5618 | 0.0030 | -0.0018 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 74.97 | 17.25 | 6762 | 5618 | 1.2034 | 1.0449 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.94 | 17.25 | 54 | 5681 | 0.0095 | 0.1462 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.94 | 17.25 | 6513 | 5681 | 1.1463 | 1.0329 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.94 | 17.25 | 5349 | 5681 | 0.9415 | 0.9856 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.94 | 17.25 | 6279 | 5681 | 1.1051 | 1.0241 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.94 | 17.25 | 18 | 5681 | 0.0032 | 0.0051 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 76.94 | 17.25 | 6994 | 5681 | 1.2310 | 1.0503 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 78.91 | 17.25 | 61 | 5730 | 0.0106 | 0.1628 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 78.91 | 17.25 | 6714 | 5730 | 1.1716 | 1.0382 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 78.91 | 17.25 | 5189 | 5730 | 0.9055 | 0.9764 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 78.91 | 17.25 | 6519 | 5730 | 1.1376 | 1.0310 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 78.91 | 17.25 | 16 | 5730 | 0.0028 | -0.0090 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 78.91 | 17.25 | 7242 | 5730 | 1.2637 | 1.0567 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 80.88 | 17.25 | 73 | 5826 | 0.0125 | 0.1874 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 80.88 | 17.25 | 6980 | 5826 | 1.1981 | 1.0435 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 80.88 | 17.25 | 5204 | 5826 | 0.8932 | 0.9733 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 80.88 | 17.25 | 6822 | 5826 | 1.1709 | 1.0379 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 80.88 | 17.25 | 12 | 5826 | 0.0021 | -0.0423 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 80.88 | 17.25 | 7512 | 5826 | 1.2894 | 1.0614 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 82.85 | 17.25 | 78 | 5861 | 0.0133 | 0.1966 | MN20160310_N02 | G13 |